Initial patient-reported outcomes of a phase II neoadjuvant apalutamide (ARN-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) trial

Patient Reported ◽

Patient-reported outcomes of neoadjuvant apalutamide (ARN-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) trial – a phase II trial

European Urology Open Science ◽

10.1016/s2666-1683(20)33701-0 ◽

2020 ◽

Vol 19 ◽

pp. e1649

Author(s):

X.Y. Yang ◽

E.J. Aslim ◽

T.W. Chong ◽

J.S.P. Yuen ◽

K.J. Tay ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Trial ◽

Patient Reported ◽

Neoadjuvant apalutamide (arn-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) – initial results of a phase II trial

European Urology Supplements ◽

10.1016/s1569-9056(19)31008-5 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1394

Author(s):

E.J. Aslim ◽

X. Yang ◽

N-T. Ngo ◽

L.Y. Khor ◽

K. Chen ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Trial ◽

Risk Prostate Cancer ◽

Initial Results

138 ADJUVANT MULTIMODALITY TREATMENT IN PATIENTS WITH HIGH RISK PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE CLINICAL PHASE-II TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(07)60137-7 ◽

2007 ◽

Vol 6 (2) ◽

pp. 57

Author(s):

A. Heidenreich ◽

C. Ohlmann ◽

D. Pfister ◽

D. Thüer ◽

U.H. Engelmann

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Trial ◽

Multimodality Treatment ◽

Clinical Phase ◽

Patient Reported Outcomes after Hypofractionated Radiotherapy and Long-term Androgen Deprivation for High-risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.817 ◽

2010 ◽

Vol 78 (3) ◽

pp. S345

Author(s):

H.C. Quon ◽

D.A. Loblaw ◽

G. Morton ◽

E. Szumacher ◽

C. Danjoux ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Androgen Deprivation ◽

Hypofractionated Radiotherapy ◽

Patient Reported ◽

Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer

BJU International ◽

10.1111/bju.12676 ◽

2015 ◽

Vol 116 (1) ◽

pp. 50-56 ◽

Cited By ~ 10

Author(s):

Jonathan L. Silberstein ◽

Stephen A. Poon ◽

Daniel D. Sjoberg ◽

Alexandra C. Maschino ◽

Andrew J. Vickers ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Trial ◽

Chemohormonal Therapy ◽

Oncological Outcomes ◽

766 FEASIBILITY OF RADICAL PROSTATECTOMY FOLLOWING NEOADJUVANT IXABEPILONE FOR HIGH-RISK PROSTATE CANCER: A PHASE II CLINICAL TRIAL

The Journal of Urology ◽

10.1016/j.juro.2013.02.330 ◽

2013 ◽

Vol 189 (4S) ◽

Cited By ~ 1

Author(s):

Michael Maddox ◽

Jodi Layton ◽

Angela Taber ◽

Anthony Mega ◽

Joseph Renzulli

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer

BJU International ◽

10.1111/j.1464-410x.2007.06760.x ◽

2007 ◽

Vol 100 (2) ◽

pp. 274-280 ◽

Cited By ~ 54

Author(s):

Tomaso Prayer-Galetti ◽

Emilio Sacco ◽

Francesco Pagano ◽

Marina Gardiman ◽

Antonio Cisternino ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Trial ◽

Risk Prostate Cancer ◽

Long Term Follow Up

MP79-05 NEOADJUVANT APALUTAMIDE (ARN-509) AND RADICAL PROSTATECTOMY IN TREATMENT OF INTERMEDIATE TO HIGH RISK PROSTATE CANCER (NEAR) PHASE II TRIAL

The Journal of Urology ◽

10.1097/ju.0000000000000971.05 ◽

2020 ◽

Vol 203 ◽

pp. e1216-e1217

Author(s):

XinYan Yang* ◽

Edwin Jonathan Aslim ◽

Nye Thane Ngo ◽

Li Yan Khor ◽

Tsung Wen Chong ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Trial ◽

Impact of Proton Therapy to the Prostate Alone Versus the Whole Pelvis on Patient-reported Outcomes and Toxicities in High-Risk Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.1016 ◽

2012 ◽

Vol 84 (3) ◽

pp. S385-S386

Author(s):

L.A. McGee ◽

B.S. Hoppe ◽

R.H. Henderson ◽

C.G. Morris ◽

R.C. Nichols ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Cancer Patients ◽

Proton Therapy ◽

Patient Reported ◽

Patient-Reported QOL Outcomes of Hypofractionated Stereotactic Body Radiation Therapy Boost for the Treatment of Localized, Non-Metastatic, High-Risk Prostate Cancer: Updated Results of a Phase II Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.533 ◽

2020 ◽

Vol 108 (3) ◽

pp. e907-e908

Author(s):

K. Cheng ◽

M.M. Qureshi ◽

M.A. Dyer ◽

B.N. Bloch ◽

G. Gignac ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii ◽

Stereotactic Body Radiation Therapy ◽

Phase Ii Trial ◽

Stereotactic Body Radiation ◽

Patient Reported ◽